Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Michal Cahal"'
Publikováno v:
Children, Vol 9, Iss 12, p 1862 (2022)
Lockdown policies have been implemented worldwide to limit the spread of COVID-19. “Lockdown fatigue” is a state of exhaustion related to the accumulating effects of repeated lockdowns. The aim of the current study was to examine the effects of r
Externí odkaz:
https://doaj.org/article/a3512a7cc0d0449eab6b26fe138ab6d0
Autor:
Shay Ehrlich, Inbal Golan Tripto, Moran Lavie, Michal Cahal, Tommy Shonfeld, Dario Prais, Hagit Levine, Meir Mei‐Zahav, Ophir Bar‐On, Yulia Gendler, Jonatan Zalcman, Eahab Sarsur, Micha Aviram, Aviv Goldbart, Patrick Stafler
Publikováno v:
Pediatric Pulmonology. 58:941-948
High-flow nasal cannula (HFNC) therapy may be better tolerated than traditional noninvasive ventilation (NIV) and is rapidly gaining acceptance in pediatric acute care. In Israel, HFNC is approved for domestic use. We aim to describe its indications,
Autor:
Moria Be'er, Israel Amirav, Michal Cahal, Mika Rochman, Yotam Lior, Ayelet Rimon, Roni G. Lavy, Moran Lavie
Publikováno v:
Pediatric Pulmonology. 57:1425-1431
To investigate whether the three nationwide coronavirus disease 2019 (COVID-19) lockdowns imposed in Israel during the full first pandemic year altered the traditional seasonality of pediatric respiratory healthcare utilization.Month by month pediatr
Autor:
Moran Lavie, Mika Rochman, Liora Sagi, Anat Yerushalmy Feler, Dror Ovadia, Michal Cahal, Moria Be'er, Efraim Sadot, Aviva Fattal‐Valevski, Israel Amirav
Publikováno v:
Pediatric Pulmonology. 57:686-694
Emergence of new treatments for spinal muscular atrophy type 1 (SMA1) has led to dramatic improvements in respiratory failure and survival. However, these "treated" patients sustain major problems in other organ systems, which may directly or indirec
Publikováno v:
Pediatric Pulmonology
Objective A national lockdown was implemented in Israel to slow the viral spread of COVID‐19. We assessed the real‐time effects of the lockdown on disease expression and lifestyle modifications in pediatric patients with chronic respiratory disor
Publikováno v:
Pediatric pulmonologyREFERENCES. 57(6)
An 8-year-old boy recently sustained a cerebellar arteriovenous malformation rupture, and subsequently suffered from severe neurological injury and became ventilator-dependent through a tracheostomy. During a routine clinic visit, the parents reporte
Autor:
Moria Be'er, Shai Bushmitz, Michal Cahal, Efraim Sadot, Sivan Yochpaz, Omri Besor, Israel Amirav, Moran Lavie
Publikováno v:
Pediatric pulmonology. 57(7)
Admission to a pediatric intensive care unit (PICU) has been associated with respiratory consequences in children with asthma and carries major implications for management control. Whereas respiratory syncytial virus (RSV) bronchiolitis has been asso
Autor:
Michal Cahal, Omri Besor, Nir Diamant, Sharon Lahat, Dror Maymon, Moran Lavie, Moria Be'er, Israel Amirav
Publikováno v:
Pediatric pulmonologyREFERENCES. 56(9)
Background Bronchiolitis is a prominent illness in children with a high burden in the developing world. Our objective was to assess bronchiolitis severity among infants and toddlers of refugees and asylum seekers who fled from developing countries wi
Autor:
Efraim Sadot, Moran Lavie, Udi Shapira, Israel Amirav, Nir Diamant, Moria Be'er, Michal Cahal, Mika Rochman, Keren Armoni-Domany
Publikováno v:
Pediatric pulmonologyREFERENCES. 56(6)
BACKGROUND Fractional exhaled nitric oxide (FeNO) is a biomarker for eosinophilic inflammation used for diagnosis and monitoring of asthma. High FeNO indicates significant airway eosinophilia and steroid-responsive airway inflammation. Some children
Autor:
Keren Armoni Domany, Aviva Fattal-Valevski, Liora Sagi, Michal Cahal, Israel Amirav, Moran Lavie, Nir Diamant, Moria Be'er, Efraim Sadot
Publikováno v:
Pediatric pulmonologyREFERENCES. 56(1)
Background The emergence of new treatments for spinal muscular atrophy (SMA) is revolutionary, especially for SMA type 1 (SMA1). Data on respiratory outcomes remain sparse and rely mostly on randomized clinical trials. We report our experience of Nus